Guidance

Patient information leaflets for antihistamine sleep aid and laxative medicines

This guidance sets what is appropriate in patient information leaflets for antihistamine sleeping aids and laxatives.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 29 December 2014

This publication was withdrawn on 1 January 2021

This content has been withdrawn as it is no longer up-to-date.

Documents

Patient information leaflets for antihistamine sleep aid and laxative medicines

PDF, 34.2 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Most medicines are used by patients safely and in accordance with the instructions for use on the patient information leaflet (PIL). There are a very small number of cases where medicines rarely may be misused or abused by patients.

In products that are known to be misused in a small proportion of cases, the PIL can help to ensure safe use by including appropriate warning messages. However, it is important to maintain a balance so that messages in the PIL do not direct patients to the possibility of misuse.

Published 29 December 2014